Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the vesting of restricted stock units into common stock.
Summary
- On April 15, 2024, Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
- 68 restricted stock units vested and were converted into 68 shares of common stock at a price of $0.
- Following the transaction, Potter directly owns 7,582 shares of common stock and 1,232 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders as it is a routine vesting of stock units.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | Initial vesting date for 25% of the restricted stock units. |
| April 15, 2024 | Date of the reported transaction where restricted stock units vested into common stock. |
| April 16, 2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.